Average Co-Inventor Count = 8.42
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (19 from 329 patents)
2. Genentech, Inc. (12 from 3,221 patents)
3. Bristol-myers Squibb Pharma Company (11 from 234 patents)
4. Bristol-myers Squibb Compnay (3 from 3,681 patents)
5. Genetech, Inc. (1 from 98 patents)
6. Covenentech, Inc. (1 from 1 patent)
7. Genertech, Inc. (1 from 1 patent)
33 patents:
1. 9409886 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
2. 9359340 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors
3. 9346805 - Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
4. 9328091 - 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
5. 9303040 - Substituted piperazines as AKT inhibitors
6. 8895566 - 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
7. 8853199 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
8. 8853216 - Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor
9. 8846681 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
10. 8846683 - Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
11. 8835434 - Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
12. 8680114 - AKT protein kinase inhibitors
13. 8618097 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
14. 8377937 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
15. 8329709 - 5H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors